EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS110-01081 
Organism
Homo sapiens 
Tissue/cell
KATO3 
Coordinate
chr12:133021530-133023340 
TF binding sites/motifs
Number: 26             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
GGTATTCTGA GGCTTCTCTC ATTTCTCCTT TATCACCATC TGCCCCACAG CAGGCAGGCC 60
CGGAGCCTCT GCAGAAGGGG GAACCGGGTG CAGGCCCAAC GCCGGTCTCT CAGTGTGGCA 120
GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT AGTTCCTACT CTGCAGCCTT GGCTGCCGGG 180
CACGGAGAAC GTTTTAGCAG AAACACCTCT GCAAAACCAC TTCCTGGCCC GGGCCCAGCC 240
AAACACCATC TTCTCCTCCA CCCCAGGGCT CCGCCCCCAT CTCCAGGCTC AGCCCAGCAC 300
CCCCACCCCC GAAACCCCCA GCCCCACTGC ATCTGCCCTG GCCATCTGCC TCCGCCCTGC 360
CTCGCTAACA CAGTTATTAA TGAGCAATTT TCCTGTAATT ACAACGCAGT TATGCCAGTT 420
ACCCCGACCT GCTGACAGAG AGCATTCACT TCCATGTGGC ACTAGCCCCC AGGCCTGAGA 480
GGACGCAAAC ACTTGCCCCT CATTCGCTGC CCCCACCCCC ACTCTGCCAG CCAGCACCAC 540
CCTCCACCCA CTCTAGGCCC TTAAGAAAGG AGGGAAGGGC CGCGGGGAGG AGCTCTCAGA 600
TCCCGAGGCC CCACTCCCCC TGCAAGGAAG GCTGTGAGCT CGGCCCCAGC CCACCTGCCA 660
GCTCCCCAAA CACCTCCCAC CTCCCTCCGC CGCCTCCTGA AGGGACTACA CTCCCCTGGC 720
TCCTCCAAAA TCCGCTAATG AACAGCAGGC GCAGAGGCTC CGCCACCGGC GTGCTCCTGG 780
CCTCAGCCCT CCCTGTTCTG AAACCGCCTT TGCTAAGACG GTAGTAGTGA GGAATCACGA 840
CAGTGGCAGA GGCCAACCTG ACCCGCTCCA CCTGCCTCCA CCCCAACCCG CCCGGCTGCT 900
TCCTGAGCGT GGGCCAAACT AACTTTGACA GGAACTTAGT TTACAGTTTA AGTTGGGAAC 960
AAAAAGGATA ACAGCCCCTC CCCAAAACAG ATTCCCTCCT CGCTTGGGGG GACCAGTCCC 1020
GTTGTAAAAC CGACAAATAA CAGCAGGATT AGGAATTCCG GCTCAGGATT CACGCAGCCA 1080
GACGCCACAG GACTCCTCCC CAGCCGCTCC TGTATATGAC GTCACCGCCG TAAGACCACA 1140
GGACACCGCC CCAGCCGCGC CTGTAGATGA CGTCACCATC GTAAGACCAC AGGACCCTTC 1200
CCAGCCGCTC CTGTATATGA CGTCACCGCC GTAAGACCAC AAGTCACCGC CCCAGCCGCT 1260
CCTGTAGATG ACGTCACCAC AGTAAGACCA CAGGATACCG CCCCAGCCGC GCCTGTAGAT 1320
GACGTCACCA TCGTAGGCCC ACAGGACCCT TCCCAGCCGC TCCTGTGGAT GACGTCACCG 1380
CCGTAGGACC TAAGATTGAT GCTGGAGAGG TTCTTCAGAC CCTGCGTTCT GACGGCTCCG 1440
CTGGCACCAC CCAGACGGGT AAACTAGCTC TTCCGGTCTG TGGCCCTCAC AGGAACCGAC 1500
TCGGTGCAGG AGGACAGCTT CAGCCCCTGT GATTTCATCC CCGACCAACC AGCCAGCACT 1560
CCCCACTCCC TAGCCCCCTG CCTGCCAAAC TATCTTTTAA AAAACTCCAG TTTCCAAATT 1620
TTCAGGGAGG CTGATTTGAG TAATAATAAA ACTCCAGTCT CCTGCTAGCT GGCTCTGGAT 1680
GCACTAGACT CTATTGCAAT TCTCCTGTCC TGATAAATCG GCTGTCAGGC AAGAAGAACC 1740
CGTTGGGTGG TTACAGTTTC AAGGCTATAT TCAGAGAACT ATCCACTAAT AAAATCTCTG 1800
TTTATGCAGT 1810